- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05207345
Effectiveness of Core Stability Training on Trunk Control in Patients With Post-hemorrhagic Stroke
Stroke is responsible for about 7% of disabilities in the European population. Intracerebral hemorrhage (ICH) represents 15% of stroke cases in Europe. In order to avoid disabling sequelae, an essential role is played by early rehabilitation, which has also proved effective for ICH.
In addition to its role in physical recovery, it plays a fundamental role in the psychological well-being of patients with ICH.
Impairments in trunk function are a common sequela and are related to reduced mobility, balance and functional independence.
Trunk exercises could improve trunk control, postural control, and functional recovery.
The hypothesis is that a specific exercise program, based on core stability, will induce clinically significant and long-term improvements from the point of view of trunk control, and secondly in postural control, disability and quality of life in subjects with hemorrhagic stroke outcomes, versus general physiotherapy, and that these improvements will be maintained at least one year after the intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Stroke is responsible for about 7% of disabilities in the European population, and in particular intracerebral hemorrhage (ICH), whose mortality is higher than ischemic stroke, represents 15% of stroke cases in Europe.
In order to avoid disabling sequelae, an essential role is played by early rehabilitation, which has also proved effective for ICH.
Patients undergoing early rehabilitation within neurorehabilitation units achieve better clinical-functional outcomes than those who receive general medical care; furthermore, in addition to its role in physical recovery, it plays a fundamental role in the psychological well-being of patients with ICH, as these patients tend to be less depressed and anxious than those undergoing standard care.
However, even after intensive rehabilitation functional deficits still exist, making stroke the leading cause of disability in adults globally.
Impairments in trunk function, in particular, are a common sequelae and are related to reduced mobility, balance and functional independence. Therefore, impairments in trunk function can lead to limitations of activity and participation, as well as to increase the risk of falling resulting in further disability, hospitalization and mortality.
The dysfunction of the core, which would significantly affect the function of the trunk, would seem to be linked to a reduction in muscle strength, to a delayed/asymmetrical activation of the muscles, as well as to proprioceptive alterations.
Following this line, trunk exercises could then improve trunk control, postural control, and functional recovery.
Looking at the literature, it has been seen how several randomized controlled trials have focused on the efficacy of trunk training in stroke populations with positive and encouraging results regarding the outcomes achieved within the experimental groups. However, these studies, in addition to including patients with both ischemic and haemorrhagic stroke, did not always equalize the amount of exercise provided with a control group, showing heterogeneity in the exercises administered, and did not consider whether the therapeutic efficacy observed at the end of the treatment is still maintained over the long term.
The hypothesis is that a specific exercise program, based on core stability, will induce clinically significant and long-term improvements from the point of view of trunk control, and secondly in postural control, disability and quality of life in subjects with hemorrhagic stroke outcomes, versus general physiotherapy, and that these improvements will be maintained at least one year after the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cagliari, Italy, 09100
- University of Cagliari
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- haemorrhagic stroke < 3 months, first event
- adulthood (40-75 years)
- ability to maintain the sitting position
- good knowledge of the Italian language
Exclusion Criteria:
- cognitive impairment
- Ashworth score> 2
- Neurodegenerative and/or neuromuscular disorders
- Severe cardiovascular and respiratory instability, systemic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
90-minute session divided into:
|
90-minute session divided into:
|
Active Comparator: General Group
90 minutes of general rehabilitation (active / active assisted / passive mobilization, stretching, posture maintenance, postural and autonomy training, cycle ergometer, exercise bike and ambulatory training).
|
90 minutes of general rehabilitation (active / active assisted / passive mobilization, stretching, posture maintenance, postural and autonomy training, cycle ergometer, exercise bike and ambulatory training).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Trunk Impairment Scale at 8 weeks and 12 months
Time Frame: Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
The Trunk Impairment Scale (TIS) is a 17-item scale that aims to assess the static, dynamic balance and coordination of the trunk.
Each item is given a variable score from 0 to 3 in relation to the performance analyzed.
The final score can range from a minimum of 0 points to a maximum of 23.
The higher the score, the more independent the patient is in performing trunk control.
Investigators used the Italian version which proved to be reliable and valid
|
Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Functional Independence Measure (FIM) at 8 weeks and 12 months
Time Frame: Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
FIM describes 18 Activities of daily living (ADLs) associated with motor, cognitive, and sphincteral problems and ranges from 18 (maximal limitation) to 126 (no limitation). Each item is scored on a 7 point ordinal scale, ranging from a score of 1 to a score of 7. The higher the score, the more independent the patient is in performing the task associated with that item. |
Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
Change from Baseline Berg Balance Scale (BBS) at 8 weeks and 12 months
Time Frame: Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function Final score ranges from 0 (high risk of falling) to 56 (no risk of falling).
|
Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
Change from Baseline Short-Form Health Survey Questionnaire at 8 weeks and 12 months
Time Frame: Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
Quality of life is assessed using the Italian version of the self-report Short-Form Health Survey with its eight domain scores ranging from 0 (the worst perceived quality of life) to 100 (the best perceived quality of life).
|
Questionnaires will be administered before treatment, eight weeks after (post-treatment) and 12 months after the end of treatment (follow-up)
|
Global Perceived Effect
Time Frame: eight weeks after starting treatment (post-treatment)
|
Global Perceived Effect is a self-administered measure of treatment satisfaction consisting of a five-level Likert scale (1=helped a lot, 2=helped, 3=helped only a little, 4=did not help, 5=made things worse).
|
eight weeks after starting treatment (post-treatment)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Marco Monticone, MD, PhD, University of Cagliari
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PG/2021/17872
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhagic Stroke
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)CompletedStroke | Stroke, Ischemic | Stroke HemorrhagicUnited States
-
IRCCS Centro San Giovanni di Dio FatebenefratelliAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria... and other collaboratorsUnknownStroke, Ischemic | Stroke HemorrhagicItaly
-
Royal Holloway UniversityRecruitingStroke | Stroke, Ischemic | Stroke HemorrhagicUnited Kingdom
-
Khyber Medical University PeshawarRecruitingStroke | Stroke, Ischemic | Stroke HemorrhagicPakistan
-
University of Kansas Medical CenterRecruiting
Clinical Trials on Interventional programme
-
Corporacion Parc TauliUnknown
-
Revmatismesykehuset ASSouth-Eastern Norway Regional Health AuthorityCompletedMusculoskeletal Diseases or ConditionsNorway
-
University of HelsinkiFinnish Medical FoundationCompleted
-
Region SkaneLund UniversityCompleted
-
Universidad San JorgeHospital Royo Villanova; Hospital Real Nuestra Señora de GraciaCompletedFatigue | Coronavirus | Musculoskeletal ComplicationSpain
-
Oxford Brookes UniversityNational Institute for Health Research, United Kingdom; Royal Berkshire NHS... and other collaboratorsCompleted
-
Medical University of LodzCompletedChronic Obstructive Pulmonary Disease (COPD)Poland
-
University of GlasgowRecruiting
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Hacettepe UniversityCompleted